MARY COLLIER: Open Payments
NPI 1497279673 · AMELIA, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$808 in 62 payments from 12 companies in 2025. Trend: 2023 $538 · 2024 $637 · 2025 $808
Food & beverage: $808
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 14 | $161 |
| Otsuka America Pharmaceutical, Inc. | 15 | $146 |
| Axsome Therapeutics, Inc. | 6 | $140 |
| ABBVIE INC. | 14 | $136 |
| Indivior Inc. | 4 | $64 |
| Alkermes, Inc. | 3 | $62 |
| Neurocrine BioSciences, Inc. | 1 | $21 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
| Janssen Pharmaceuticals, Inc | 1 | $17 |
| E.R. Squibb & Sons, L.L.C. | 1 | $14 |
Products named: CAPLYTA, Auvelity, REXULTI, VRAYLAR, SUBLOCADE, MAVYRET, ABILIFY ASIMTUFII, ARISTADA.
Industry payments across OH — which companies pay providers there.
